{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:11:41Z","timestamp":1787897501326,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.tube.2021.102104","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T03:42:54Z","timestamp":1623987774000},"page":"102104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["A multi-targeting pre-clinical candidate against drug-resistant tuberculosis"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9154-3278","authenticated-orcid":false,"given":"Parvinder","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Potluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Kamal","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.N.","family":"Naveenkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya Vadageri","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi Thimmalapura","family":"Gangadharaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Shivarudraiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumesh","family":"Eswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy Rosaline","family":"Nirmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasubramanian","family":"Mahizhaveni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azger","family":"Dusthackeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Batt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Loman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5605-0395","authenticated-orcid":false,"given":"Gurdyal Singh","family":"Besra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha Krishan","family":"Shandil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7781-7399","authenticated-orcid":false,"given":"Shridhar","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2021.102104_bib1","series-title":"Global tuberculosis report 2020","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.tube.2021.102104_bib3","author":"Centers for Disease Control and Prevention"},{"issue":"10","key":"10.1016\/j.tube.2021.102104_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2021.102104_bib5","article-title":"Molecule property analyses of active compounds for","author":"Vadim","year":"2020","journal-title":"Mycobacterium Tuberculosis. J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bmcl.2018.11.002","article-title":"Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety","volume":"29","author":"Shruthi","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2021.102104_bib8","series-title":"FNDR-20081- A novel pre-clinical candidate for treatment of TB\/MDR tuberculosis. AAR# 736, 21st june 2019, control #: 5054","author":"Kaur","year":"2019"},{"key":"10.1016\/j.tube.2021.102104_bib9","unstructured":"CLSI- Clinical and Laboratory Standards Institute (CLSI), Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes 940 west valley road, Suite 1400, Wayne, PA 19087 USA."},{"key":"10.1016\/j.tube.2021.102104_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2021.102104_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117577","article-title":"A high-throughput cidality screen for Mycobacterium tuberculosis","volume":"10","author":"Kaur","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2021.102104_bib12","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1021\/jm401382v","article-title":"Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts kill Mycobacterium tuberculosis and are efficacious in vivo","volume":"56","author":"Shirude","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1128\/AAC.00414-06","article-title":"Moxifloxacin, Ofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy","volume":"51","author":"Shandil","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102104_bib14","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/AAC.47.7.2118-2124.2003","article-title":"Pharmacokinetic-pharmacodynamic relationships for rifampicin in an aerosol infection model of tuberculosis","volume":"47","author":"Jayaram","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102104_bib15","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/AAC.48.8.2951-2957.2004","article-title":"Isoniazid pharmacokinetics-pharmacodynamics in aerosol infection model of tuberculosis","volume":"48","author":"Jayaram","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102104_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154513","article-title":"Unravelling the secrets of mycobacterial cidality through the lens of antisense","volume":"11","author":"Kaur","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2021.102104_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222970","article-title":"A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against nonreplicating Mycobacterium tuberculosis","volume":"14","author":"Early","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2021.102104_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1021\/acsinfecdis.5b00065","article-title":"Whole cell target engagement identifies novel inhibitors of Mycobacterium tuberculosis decaprenylphosphoryl-\u03b2-d-ribose oxidase","volume":"1","author":"Batt","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.tube.2021.102104_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tube.2008.08.003","article-title":"Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system","volume":"89","author":"Milano","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2021.102104_bib20","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.00037-14","article-title":"Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis","volume":"58","author":"Hartkoorn","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102104_bib21","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/j.bmc.2009.02.026","article-title":"Design, synthesis, biological evaluation, and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis","volume":"17","author":"Upadhayaya","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib22","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.bmc.2009.01.013","article-title":"Synthesis and in vitro antitubercular activity of a series of quinoline derivatives","volume":"17","author":"de Souza","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1021\/jm00400a016","article-title":"Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids","volume":"31","author":"Sanchez","year":"1988","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib24","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1021\/jm900003c","article-title":"Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis","volume":"52","author":"Lilienkampf","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00044-010-9522-z","article-title":"An efficient one-pot cyclization of quinoline thiosemicarbazones to quinolines derivatized with 1,3,4-thiadiazole as anticancer and anti-tubercular agents","volume":"21","author":"Marganakop","year":"2012","journal-title":"Med Chem Res"},{"key":"10.1016\/j.tube.2021.102104_bib26","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/j.ejmech.2010.04.022","article-title":"New quinoline derivatives: synthesis and investigation of antibacterial and antituberculosis properties","volume":"45","author":"Eswaran","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/acsmedchemlett.5b00324","article-title":"2-(Quinolin-4-yloxy)acetamides are active against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains","volume":"7","author":"Pissinate","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.tube.2021.102104_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2016.11.048","article-title":"New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis","volume":"126","author":"Giacobbo","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib29","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1039\/C6MD00236F","article-title":"SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc1 inhibitors","volume":"7","author":"Phummarin","year":"2016","journal-title":"Med Chem Comm"},{"key":"10.1016\/j.tube.2021.102104_bib30","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.bmcl.2018.04.028","article-title":"Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosis","volume":"28","author":"Martinez-Grau","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2021.102104_bib31","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1016\/j.bmc.2011.04.033","article-title":"Antimycobacterial activity of novel 1,2,4-oxadiazole-pyranopyridine\/chromene hybrids generated by chemoselective 1,3-dipolar cycloadditions of nitrile oxides","volume":"19","author":"Kumar","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejmech.2012.04.021","article-title":"Solvent free, four component synthesis and 1,3-dipolar cycloaddition of 4(h)-pyrans with nitrile oxides: synthesis and discovery of antimycobacterial activity of enantiomerically pure 1,2,4-oxadiazoles","volume":"53","author":"Almansour","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib33","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1016\/j.bmcl.2012.08.061","article-title":"Synthesis and evaluation of novel 1,3,4-oxadiazole derivatives of marine bromopyrrole alkaloids as antimicrobial agent","volume":"22","author":"Rane","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2021.102104_bib34","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/acs.jmedchem.5b00608","article-title":"Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and thiadiazoles as selective antitubercular agents active against replicating and nonreplicating Mycobacterium tuberculosis","volume":"59","author":"Karabanovich","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejmech.2016.11.041","article-title":"S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents","volume":"126","author":"Karabanovich","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib36","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1021\/acs.jmedchem.6b00031","volume":"59","author":"Bhakta","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib37","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.bmcl.2016.03.059","article-title":"Seeking potent anti-tubercular agents: design, synthesis, anti-tubercular activity and docking study of various ((triazoles\/indole)-piperazin-1-yl\/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives","volume":"26","author":"Naidu","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2021.102104_bib38","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.ejmech.2011.03.039","article-title":"New quinolin-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines as potential antitubercular agents","volume":"46","author":"Thomas","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib39","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1128\/AAC.40.9.2021","article-title":"Expression of the multidrug resistance operon mexA\u2013mexB\u2013oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression","volume":"40","author":"Poole","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102104_bib40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1054\/tuld.1999.0220","article-title":"Analysis of the proteome of Mycobacterium tuberculosis in silico","volume":"79","author":"Tekaia","year":"1999","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.tube.2021.102104_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003120","article-title":"Discovery of a siderophore export system essential for virulence of Mycobacterium tuberculosis","volume":"9","author":"Wells","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2021.102104_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1311402111","article-title":"Self-poisoning of Mycobacterium tuberculosis by interrupting siderophore recycling","volume":"111","author":"Jones","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.tube.2021.102104_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","article-title":"Genes required for mycobacterial growth defined by high density mutagenesis","volume":"48","author":"Sassetti","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2021.102104_bib44","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1021\/jm500131s","article-title":"Multitarget drug discovery for tuberculosis and other infectious diseases","volume":"57","author":"Li","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib45","article-title":"A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK","volume":"8","author":"Laurent","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2021.102104_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-21614-4","article-title":"A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK","volume":"8","author":"Chiarelli","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2021.102104_bib47","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.9b02075","article-title":"Molecule property analyses of active compounds for Mycobacterium tuberculosis","author":"Makarov","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2021.102104_bib48","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1039\/C9MD00057G","article-title":"Drug-resistance in Mycobacterium tuberculosis: where we stand","volume":"10","author":"Mabhula","year":"2019","journal-title":"Med Chem Comm"},{"key":"10.1016\/j.tube.2021.102104_bib49","first-page":"1","article-title":"Multi-target antitubercular drugs","volume":"18","author":"de Oliveira","year":"2018","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"10.1016\/j.tube.2021.102104_bib50","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AAC.05708-11","article-title":"2019. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis","volume":"56","author":"Tahlan","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102104_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.553962","article-title":"High-content screening of eukaryotic kinase inhibitors 1 identify CHK2 inhibitor activity against Mycobacterium tuberculosis","author":"Shapira","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2021.102104_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m216","article-title":"Current and future treatments for tuberculosis","author":"Lee","year":"2020","journal-title":"BMJ:m216"},{"key":"10.1016\/j.tube.2021.102104_bib53","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(00)03493-0","article-title":"Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection","volume":"356","author":"Hernandez-Pando","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2021.102104_bib54","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2741\/1293","article-title":"The search for new sterilizing anti-tuberculosis drugs","volume":"9","author":"Mitchison","year":"2004","journal-title":"Front Biosci"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979221000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979221000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:44:55Z","timestamp":1761468295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979221000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":52,"alternative-id":["S1472979221000548"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2021.102104","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multi-targeting pre-clinical candidate against drug-resistant tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2021.102104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102104"}}